Back
Vanguard FTSE All-World ex-US Small-Cap Index ETF Vs. Novartis AG Industry Stock Comparison
Sell
34
VSS
Vanguard FTSE All-World ex-US Small-Cap Index ETF
Last Price:
$143.87
Seasonality Move:
0.89%
Buy
64
NVSEF
Novartis AG
Last Price:
$138.87
Seasonality Move:
-4.22%
Sell
34
Vanguard FTSE All-World ex-US Small-Cap Index ETF (VSS)
is a Sell
Is Vanguard FTSE All-World ex-US Small-Cap Index ETF a Buy, Sell or Hold?
-
The current Vanguard FTSE All-World ex-US Small-Cap Index ETF [VSS] share price is $142.94. The Score for VSS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
VSS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $133.75. The Score for NVSEF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VSS Stock Price Chart
What is Vanguard FTSE All-World ex-US Small-Cap Index ETF's stock price today?
-
The Vanguard FTSE All-World ex-US Small-Cap Index ETF share price today is $142.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VSS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $133.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
VSS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 31.78 | Buy |
| Relative Strength Index (14 RSI): | 50.74 | Buy |
| Chaikin Money Flow: | 401558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (139.89 - 144.47) | Buy |
| Bollinger Bands (100): | (138.73 - 143.85) | Buy |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 58.05 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (125.18 - 131.84) | Buy |
| Bollinger Bands (100): | (120.61 - 131.23) | Buy |
VSS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 143.71 | Sell |
| 20-day SMA: | 143.1 | Sell |
| 50-day SMA: | 142.18 | Buy |
| 200-day SMA: | 133.12 | Buy |
| 8-day EMA: | 90.6 | Buy |
| 20-day EMA: | 47.16 | Buy |
| 50-day EMA: | 21.14 | Buy |
| 200-day EMA: | 5.61 | Buy |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.04 | Buy |
| 20-day SMA: | 129.31 | Buy |
| 50-day SMA: | 128.22 | Buy |
| 200-day SMA: | 119.48 | Buy |
| 8-day EMA: | 130.9 | Buy |
| 20-day EMA: | 129.45 | Buy |
| 50-day EMA: | 127.97 | Buy |
| 200-day EMA: | 120.79 | Buy |
Vanguard FTSE All-World ex-US Small-Cap Index ETF Earnings Growth & VSS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vanguard FTSE All-World ex-US Small-Cap Index ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||